Video content above is prompted by the following questions: Please review the oral JAK inhibitors that have been approved for atopic dermatitis (AD). Which patients are they approved for? What makes JAK inhibitors an attractive option for AD treatment? How are oral JAK inhibitors utilized in other diseases?